A panelist discusses how real-world data presented at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) ...

The FDA approved tapinarof cream 1% (Vtama) for eczema in individuals ages 2 years and older, drugmaker Organon announced on Monday. Approval of the topical aryl hydrocarbon receptor agonist was ...

Recent clinical studies have started showing the benefits of using vitamin B12 cream to help manage dermatitis. Vitamin B12 ...

Data that shows reduction in disease severity and symptom improvement The ZORYVE cream 0.15% clinical trial program showed its potential in effectively managing the symptoms of atopic dermatitis.

Atopic dermatitis (AD) highlights from the 2025 American Academy of Dermatology Annual Meeting include phase 3 trial results on rocatinlimab and delgocitinib, findings on tapinarof 1% cream ...